JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.07B |
| 2 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.82B |
| 3 |
AT&T
T
|
+$779M |
| 4 |
Gilead Sciences
GILD
|
+$774M |
| 5 |
Eli Lilly
LLY
|
+$590M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.06B |
| 2 |
MON
Monsanto Co
MON
|
+$890M |
| 3 |
CVS Health
CVS
|
+$779M |
| 4 |
SLB Ltd
SLB
|
+$600M |
| 5 |
Chevron
CVX
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.33% |
| 2 | Healthcare | 12.01% |
| 3 | Technology | 10.9% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Unifirst Corp
UNF
$5.31B
| $1.46M | ﹤0.01% |
13,041
-18,053
| -58% | -$2.1M |
|
|
AVX
2927
DELISTED
AVX Corporation
AVX
| $1.46M | ﹤0.01% |
108,290
-1,704
| -2% | -$24.1K |
|
|
ALOG
2928
DELISTED
Analogic Corp
ALOG
| $1.45M | ﹤0.01% |
18,434
-4,133
| -18% | -$349K |
|
|
ASNA
2929
DELISTED
Ascena Retail Group, Inc.
ASNA
| $1.45M | ﹤0.01% |
4,361
-43,061
| -91% | -$13.2M |
|
2930
SunCoke Energy
SXC
$717M
| $1.45M | ﹤0.01% |
111,482
-392,861
| -78% | -$6.19M |
|
|
GI
2931
DELISTED
EndoChoice Holdings, Inc.
GI
| $1.45M | ﹤0.01% |
+88,461
| New | +$1.47M |
|
|
FSB
2932
DELISTED
Franklin Financial Network, Inc.
FSB
| $1.44M | ﹤0.01% |
+62,700
| New | +$1.34M |
|
2933
Vanguard Extended Market ETF
VXF
$30.4B
| $1.44M | ﹤0.01% |
15,599
+3,670
| +31% | +$341K |
|
2934
Greenlight Captial
GLRE
$552M
| $1.43M | ﹤0.01% |
48,836
-35,497
| -42% | -$1.08M |
|
|
MPT
2935
Medical Properties Trust
MPT
$2.81B
| $1.42M | ﹤0.01% |
108,575
-201
| -0.2% | -$2.8K |
|
2936
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
| $1.42M | ﹤0.01% |
12,900
-2,100
| -14% | -$232K |
|
2937
Phibro Animal Health
PAHC
$1.48B
| $1.42M | ﹤0.01% |
36,475
-2,773
| -7% | -$95.7K |
|
2938
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.24B
| $1.42M | ﹤0.01% |
53,889
+3,790
| +8% | +$117K |
|
|
MJCO
2939
DELISTED
Majesco
MJCO
| $1.41M | ﹤0.01% |
+268,008
| New | +$1.36M |
|
2940
CBIZ
CBZ
$3B
| $1.41M | ﹤0.01% |
145,754
-228
| -0.2% | -$2.13K |
|
2941
Semtech
SMTC
$10.7B
| $1.4M | ﹤0.01% |
+70,580
| New | +$1.64M |
|
2942
AppFolio
APPF
$6.23B
| $1.4M | ﹤0.01% |
+99,200
| New | +$1.38M |
|
2943
abrdn Physical Palladium Shares ETF
PALL
$635M
| $1.39M | ﹤0.01% |
106,310
| – | – |
|
|
WCC
2944
WESCO International
WCC
$16.7B
| $1.39M | ﹤0.01% |
20,192
-29,482
| -59% | -$2.11M |
|
2945
Cogent Communications
CCOI
$663M
| $1.38M | ﹤0.01% |
40,774
+32,846
| +414% | +$1.1M |
|
2946
Columbia Emerging Markets Consumer ETF
ECON
$325M
| $1.38M | ﹤0.01% |
52,859
+21,109
| +66% | +$569K |
|
2947
Teekay
TK
$983M
| $1.38M | ﹤0.01% |
32,141
+26,121
| +434% | +$1.24M |
|
2948
WisdomTree International High Dividend Fund
DTH
$655M
| $1.37M | ﹤0.01% |
32,487
+13,681
| +73% | +$611K |
|
|
NAV
2949
DELISTED
Navistar International
NAV
| $1.37M | ﹤0.01% |
60,564
-127,127
| -68% | -$3.48M |
|
2950
Valmont Industries
VMI
$9.2B
| $1.37M | ﹤0.01% |
11,528
+2,910
| +34% | +$359K |
|
Similar funds
JP Morgan Chase's Q2 2015 Portfolio in Review
As of Q2 2015, JP Morgan Chase held 4,397 positions worth $424B, down 3.4% from $439B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2015 filing shows 356 new, 1,656 increased, 1,613 reduced and 411 closed positions. Its largest new stake was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M. The largest sale was Johnson & Johnson, an estimated $1.06B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
- JP Morgan Chase's largest Q2 2015 buy was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.07B increase.
- JP Morgan Chase's biggest Q2 2015 reduction was Johnson & Johnson, cutting an estimated $1.06B.
- JP Morgan Chase fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $342M.
- JP Morgan Chase's ten largest holdings make up 17% of its $424B portfolio in Q2 2015.
- JP Morgan Chase opened 356 new positions and closed 411 in Q2 2015.
- JP Morgan Chase's portfolio value fell 3.4% quarter-over-quarter to $424B.
Based on JP Morgan Chase's 13F filing for Q2 2015, filed 14 Aug 2015.